ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 96 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2015. The put-call ratio across all filers is 1.93 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,003,579 | +15.7% | 1,238,986 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $867,290 | -0.8% | 1,238,986 | 0.0% | 0.01% | -11.1% |
| Q4 2022 | $874,724 | -66.9% | 1,238,986 | -28.7% | 0.01% | -71.0% |
| Q3 2022 | $2,641,000 | +16.8% | 1,737,211 | +1005.3% | 0.03% | +47.6% |
| Q2 2016 | $2,262,000 | +2.2% | 157,176 | +2.1% | 0.02% | +5.0% |
| Q1 2016 | $2,213,000 | -17.6% | 153,986 | +23.2% | 0.02% | -31.0% |
| Q4 2015 | $2,686,000 | – | 125,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,183,795 | $49,026,000 | 25.32% |
| Miura Global Management | 960,000 | $21,552,000 | 5.62% |
| Selkirk Management LLC | 440,000 | $9,878,000 | 5.40% |
| NEXT CENTURY GROWTH INVESTORS LLC | 505,633 | $11,351,000 | 1.36% |
| Geneos Wealth Management Inc. | 407,429 | $9,146,000 | 0.91% |
| Trellus Management Company, LLC | 29,186 | $655,000 | 0.90% |
| Cannell & Co. | 1,096,239 | $24,611,000 | 0.85% |
| CHARTIST INC /CA/ | 64,765 | $1,453,974,000 | 0.68% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,480,000 | 0.58% |
| Intrinsic Edge Capital Management LLC | 102,082 | $2,292,000 | 0.45% |